Covered recipient · General Payments record
JAMES BLACKWOOD
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$4,999.05
- Reported across 331 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $632.22 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $137.68 | 8 |
| Corium, Inc. | $98.40 | 6 |
| ITI, Inc. | $56.76 | 2 |
| PFIZER INC. | $55.87 | 3 |
| Novo Nordisk AS | $51.88 | 3 |
| Amgen Inc. | $45.48 | 3 |
| Sumitomo Pharma America, Inc. | $42.79 | 2 |
| Exact Sciences Corporation | $34.50 | 2 |
| Corcept Therapeutics | $28.20 | 1 |
| DEXCOM, INC. | $21.61 | 1 |
| Acerta Pharma LLC | $20.55 | 1 |
| Lilly USA, LLC | $19.66 | 1 |
| TOLMAR, INC. | $18.84 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $11.19 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106769408 | CMS |
| ABBVIE INC. | $18.31 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106769412 | CMS |
| ABBVIE INC. | $21.04 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106769416 | CMS |
| ABBVIE INC. | $20.94 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106769420 | CMS |
| ABBVIE INC. | $14.96 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106769426 | CMS |
| ABBVIE INC. | $9.73 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106769431 | CMS |
| ABBVIE INC. | $14.02 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106769435 | CMS |
| ABBVIE INC. | $27.49 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106769444 | CMS |
| Amgen Inc. | $15.12 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117508782 | CMS |
| Amgen Inc. | $16.96 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117508784 | CMS |
| Amgen Inc. | $13.40 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117508786 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.55 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105597045 | CMS |
| Corcept Therapeutics | $28.20 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117760544 | CMS |
| Corium, LLC | $15.09 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100112596 | CMS |
| Corium, LLC | $15.99 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100110236 | CMS |
| Corium, LLC | $20.76 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100095259 | CMS |
| Corium, LLC | $0.59 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100138593 | CMS |
| Corium, LLC | $22.49 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100089918 | CMS |
| Corium, LLC | $23.48 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100187926 | CMS |
| Dexcom, Inc. | $21.61 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153364066 | CMS |
| Exact Sciences Corporation | $14.68 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114593686 | CMS |
| Exact Sciences Corporation | $19.82 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114593690 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $26.31 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143377549 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $30.45 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143377553 | CMS |
| Lilly USA, LLC | $19.66 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135687926 | CMS |
| Novo Nordisk Inc | $18.21 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100483749 | CMS |
| Novo Nordisk Inc | $17.24 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100591330 | CMS |
| Novo Nordisk Inc | $16.43 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100458038 | CMS |
| PFIZER INC. | $20.58 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130995048 | CMS |
| PFIZER INC. | $17.94 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131150781 | CMS |
| PFIZER INC. | $17.35 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130899214 | CMS |
| Sumitomo Pharma America, Inc. | $19.46 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148945341 | CMS |
| Sumitomo Pharma America, Inc. | $23.33 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148945343 | CMS |
| Tolmar, Inc. | $18.84 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138717582 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.